Brief: Pharmena Signs Deal For Cooperation On Pre-Clinical Tests Of 1-MMNA Candidate For Covid-19 Drug

Pharmena SA

22/10/2020 13:57

Oct 22 (Reuters) - Pharmena SA  PHR.WA :
    * SIGNS DEAL WITH US-BASED RESEARCH CENTRE COVANCE INC. RE
COOPERATION ON PRE-CLINICAL TESTS OF 1-MNA CANDIDATE FOR
COVID-19 DRUG ON ANIMAL MODELS
    * TESTS TO DERETMINE EFFECTIVE DOSE OF 1-MNA NECESSARY TO
PERFORM
CLINICAL TESTS ON HUMANS IN SARS-COV-2 INFECTION

Source text for Eikon:  ID:nEM8RS1hGa 
Further company coverage:  PHR.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))